IgA Nephropathy News : GoldBamboo.com http://goldbamboo.com/ IgA Nephropathy News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved Pharmacopeia's DARA Program For Hypertension And Diabetic Nephropathy Advances Into Phase 1 Clinical Trials http://goldbamboo.com/news-a220839.html Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced the initiation of a Phase 1 clinical study of PS433540, the company's lead internal product candidate. [click link for full article] Thu, 15 Feb 2007 08:00 EST Medical Society Advises Physicians On How To Minimize Dangers Of Contrast Dye - To Prevent Kidney Damage After Imaging Procedures http://goldbamboo.com/news-a212944.html The Society for Cardiovascular Angiography and Interventions (SCAI) has released recommendations for the prevention of contrast induced nephropathy (CIN) - potentially fatal kidney damage that can occur when a special dye is injected during certain cardiovascular procedures. [click link for full article] Mon, 25 Dec 2006 03:00 EST Radiant Medical Trial Shows Promising Results In Preventing Kidney Damage http://goldbamboo.com/news-a210548.html Endovascular therapeutic hypothermia may help prevent radiocontrast nephropathy (RCN), a cause of kidney failure, according to the results of a clinical feasibility trial presented at the recent American Heart Association's Scientific Sessions 2006 in Chicago. Radiant Medical, Inc. [click link for full article] Fri, 08 Dec 2006 08:00 EST Preventing Kidney Damage After Imaging Procedures: How To Minimize Dangers Of Contrast Dye http://goldbamboo.com/news-a210966.html The Society for Cardiovascular Angiography and Interventions (SCAI) has released recommendations for the prevention of contrast induced nephropathy (CIN) -- potentially fatal kidney damage that can occur when a special dye is injected during certain cardiovascular procedures. The consensus document, the first to be written on this topic, appears in the January 2007 issue of Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions. Mon, 11 Dec 2006 04:00 EST New Treatment A Success For Anaemia Associated With Chronic Kidney Disease http://goldbamboo.com/news-a198437.html The first anti-anaemia treatment produced in a human cell line, DYNEPO® (epoetin delta), can effectively control anaemia in patients with chronic kidney disease (CKD[1]) according to two Phase III studies presented for the first time today.1,2  Patients with kidney disease as a result of diabetes (diabetic nephropathy) were amongst the population effectively treated with this new treatment. [click link for full article] Sat, 16 Sep 2006 07:00 EST